First reported 15 hours ago -
Updated 15 hours ago -
LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III
clinical trial for the treatment of relapsing multiple sclerosis ...
[Published BioSpace - 15 hours ago]